Vbi Vaccines Stock Analysis

VBIV -  USA Stock  

USD 1.74  0.09  4.92%

The big decline in price over the last few months for Vbi Vaccinesmay raise some interest from sophisticated investors as it is trading at a share price of 1.74 on 3,560,100 in trading volume. The company directors and management failed to add value to investors and positioning the company supply of money to exploit market volatility in December. However, diversifying your holdings with Vbi Vaccines or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.11. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Vbi Vaccines partners.
Also, please take a look at World Market Map.

Vbi Vaccines Stock Analysis 

The Vbi Vaccines stock analysis report makes it easy to digest most publicly released information about Vbi Vaccines and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Vbi Vaccines Stock analysis module also helps to analyze the Vbi Vaccines price relationship with some important fundamental indicators such as market cap and management efficiency.

Vbi Vaccines Stock Analysis Notes

About 48.0% of the company outstanding shares are owned by institutional investors. The book value of Vbi Vaccines was at this time reported as 0.62. The company recorded a loss per share of 0.26. Vbi Vaccines next dividend is scheduled to be issued on the December 12, 2012. The entity had 1:5 split on the 2nd of May 2016. VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts. Vbi Vaccines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 127 people. For more information please call Jeff Baxter at 617 830 3031 or visit https://www.vbivaccines.com.

Vbi Vaccines Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Vbi Vaccines' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Vbi Vaccines or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Vbi Vaccines generated a negative expected return over the last 90 days
Vbi Vaccines has high historical volatility and very poor performance
Vbi Vaccines may become a speculative penny stock
Vbi Vaccines has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 714 K. Net Loss for the year was (66.33 M) with loss before overhead, payroll, taxes, and interest of (8.11 M).
Vbi Vaccines currently holds about 137.47 M in cash with (37.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.53.

Vbi Vaccines Upcoming and Recent Events

Earnings reports are used by Vbi Vaccines to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Vbi Vaccines previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report5th of January 2017
Next Fiscal Quarter End30th of September 2016
Last Quarter Report30th of June 2016
Last Earning Announcement30th of September 2015

Vbi Vaccines Largest EPS Surprises

Earnings surprises can significantly impact Vbi Vaccines' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Vbi Vaccines Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Vbi Vaccines is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vbi Vaccines backward and forwards among themselves. Vbi Vaccines' institutional investor refers to the entity that pools money to purchase Vbi Vaccines' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Fny Investment Advisers LlcCommon Shares13 K30 K
Wealth Alliance Advisory Group LlcCommon Shares12 K28 K
Spire Wealth ManagementCommon Shares1000K
Perceptive Advisors LlcCommon Shares55 M171.2 M
Blackrock IncCommon Shares12.8 M39.8 M
State Street CorpCommon Shares12.2 M37.9 M
Vanguard Group IncCommon Shares5.4 M16.8 M
Susquehanna International Group LlpPut Options585.3 K1.8 M
Note, although Vbi Vaccines' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Vbi Vaccines Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 470.87 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vbi Vaccines's market, we take the total number of its shares issued and multiply it by Vbi Vaccines's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (18.1) % which means that it has lost $18.1 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (40.7) %, meaning that it created substantial loss on money invested by shareholders. Vbi Vaccines management efficiency ratios could be used to measure how well vbi vaccines manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 23rd of January, Vbi Vaccines has the risk adjusted performance of (0.13), and Coefficient Of Variation of (621.12). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vbi Vaccines, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Vbi Vaccines, which can be compared to its competition. Please validate Vbi Vaccines coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Vbi Vaccines is priced more or less accurately, providing market reflects its prevalent price of 1.74 per share. Please also confirm Vbi Vaccines total risk alpha, which is currently at (0.46) to double-check the company can sustain itself at a future point.

Vbi Vaccines Price Movement Analysis

The output start index for this execution was thirty-nine with a total number of output elements of twenty-two. View also all equity analysis or get more info about mavp overlap studies indicator.

Vbi Vaccines Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vbi Vaccines insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vbi Vaccines' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Vbi Vaccines insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Vbi Vaccines Predictive Daily Indicators

Vbi Vaccines intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Vbi Vaccines stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Vbi Vaccines Forecast Models

Vbi Vaccines time-series forecasting models is one of many Vbi Vaccines' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Vbi Vaccines' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Vbi Vaccines Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Vbi Vaccines stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Vbi Vaccines shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Vbi Vaccines. By using and applying Vbi Vaccines Stock analysis, traders can create a robust methodology for identifying Vbi Vaccines entry and exit points for their positions.
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts. Vbi Vaccines operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 127 people.

Current Vbi Vaccines Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Vbi Vaccines analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Vbi Vaccines analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
9.38Strong Buy4Odds
Vbi Vaccines current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Vbi Vaccines analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Vbi Vaccines stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Vbi Vaccines, talking to its executives and customers, or listening to Vbi Vaccines conference calls.
Vbi Vaccines Analyst Advice Details

Vbi Vaccines Stock Analysis Indicators

Vbi Vaccines stock analysis indicators help investors evaluate how Vbi Vaccines stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Vbi Vaccines shares will generate the highest return on investment. By understating and applying Vbi Vaccines stock analysis, traders can identify Vbi Vaccines position entry and exit signals to maximize returns.
Quick Ratio4.26
Fifty Two Week Low1.8300
Revenue Growth-64.10%
Shares Short Prior Month20.79M
Average Daily Volume Last 10 Day2.77M
Average Daily Volume In Three Month3.59M
Shares Percent Shares Out7.32%
Short Percent Of Float10.04%
Forward Price Earnings-6.78
Float Shares190.53M
Fifty Two Week High4.8300
Enterprise Value To Ebitda-8.23
Fifty Day Average2.5180
Two Hundred Day Average3.0150
Enterprise Value To Revenue686.98
Also, please take a look at World Market Map. Note that the Vbi Vaccines information on this page should be used as a complementary analysis to other Vbi Vaccines' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Vbi Vaccines Stock analysis

When running Vbi Vaccines price analysis, check to measure Vbi Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vbi Vaccines is operating at the current time. Most of Vbi Vaccines' value examination focuses on studying past and present price action to predict the probability of Vbi Vaccines' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vbi Vaccines' price. Additionally, you may evaluate how the addition of Vbi Vaccines to your portfolios can decrease your overall portfolio volatility.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Valuation
Check real value of public entities based on technical and fundamental data
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Is Vbi Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vbi Vaccines. If investors know Vbi Vaccines will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vbi Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vbi Vaccines is measured differently than its book value, which is the value of Vbi Vaccines that is recorded on the company's balance sheet. Investors also form their own opinion of Vbi Vaccines' value that differs from its market value or its book value, called intrinsic value, which is Vbi Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vbi Vaccines' market value can be influenced by many factors that don't directly affect Vbi Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vbi Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine Vbi Vaccines value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vbi Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.